Long-Term Outcomes of Pembrolizumab Plus Pemetrexed–Platinum in Patients With Nonsquamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
J. Clin. Oncol 2023 Feb 21;[EPub Ahead of Print], MC Garassino, S Gadgeel, G Speranza, E Felip, E Esteban, M Dómine, MJ Hochmair, SF Powell, HG Bischoff, N Peled, F Grossi, RR Jennens, M Reck, R Hui, EB Garon, T Kurata, JE Gray, P Schwarzenberger, E Jensen, MC Pietanza, D Rodríguez-AbreuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.